CNR Institutional Research Information System

DE ROSA, VIVIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.104
NA - Nord America 559
EU - Europa 318
SA - Sud America 141
AF - Africa 12
OC - Oceania 1
Totale 2.135
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 524
SG - Singapore 439
CN - Cina 221
HK - Hong Kong 212
BR - Brasile 112
IT - Italia 107
VN - Vietnam 88
FR - Francia 64
JP - Giappone 47
NL - Olanda 40
KR - Corea 33
FI - Finlandia 28
DE - Germania 23
GB - Regno Unito 19
CA - Canada 18
AR - Argentina 13
MX - Messico 13
IN - India 12
BD - Bangladesh 11
EC - Ecuador 9
IQ - Iraq 7
ZA - Sudafrica 7
ES - Italia 6
ID - Indonesia 5
IE - Irlanda 5
RU - Federazione Russa 5
JO - Giordania 4
TR - Turchia 4
CO - Colombia 3
IL - Israele 3
KH - Cambogia 3
LV - Lettonia 3
UA - Ucraina 3
AT - Austria 2
MA - Marocco 2
NP - Nepal 2
PH - Filippine 2
PK - Pakistan 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SE - Svezia 1
TH - Thailandia 1
UY - Uruguay 1
Totale 2.135
Salva come PNG Salva come JPEG
Città #
Singapore 276
Hong Kong 211
Santa Clara 183
San Jose 71
Beijing 64
Hefei 61
Lauterbourg 49
Naples 48
Ashburn 46
Tokyo 42
Seoul 33
Ho Chi Minh City 27
Hanoi 24
Los Angeles 23
Lappeenranta 16
Casandrino 13
New York 12
Frankfurt am Main 11
Helsinki 11
São Paulo 11
Council Bluffs 9
Buffalo 7
Belleville 6
Chicago 6
Mexico City 6
Rome 6
Boardman 5
Brooklyn 5
Dallas 5
Des Moines 5
Dublin 5
Orem 5
Amsterdam 4
Da Nang 4
Düsseldorf 4
Hangzhou 4
London 4
Amman 3
Baghdad 3
Bauru 3
Belo Horizonte 3
Bengaluru 3
Buenos Aires 3
Carapicuíba 3
Chennai 3
Guayaquil 3
Haiphong 3
Istanbul 3
Johannesburg 3
Milan 3
Minamishinagawa 3
Paris 3
Phnom Penh 3
Poplar 3
Quito 3
Ribeirão Preto 3
Riga 3
Shanghai 3
Atlanta 2
Biên Hòa 2
Bonito 2
Boston 2
Bratislava 2
Can Tho 2
Erbil 2
Falkenstein 2
Fortaleza 2
Ha Long 2
Houston 2
Hòa Bình 2
Hải Dương 2
Lajeado 2
Madrid 2
Manchester 2
Manila 2
Minneapolis 2
Montreal 2
Moscow 2
Munich 2
Nha Trang 2
Phoenix 2
Phủ Lý 2
Pisa 2
Piscataway 2
Porto Alegre 2
Praia Grande 2
Quận Chín 2
Rio de Janeiro 2
Sarasota 2
Shenzhen 2
Soccavo 2
Tashkent 2
Thái Nguyên 2
Vitória da Conquista 2
Xi'an 2
Abaetetuba 1
Afragola 1
Airola 1
Alenquer Municipality 1
Ambarnath 1
Totale 1.464
Salva come PNG Salva come JPEG
Nome #
Monitoring Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer by 18F-FLT PET/CT 75
18F-FLT PET/CT imaging and inhibition of multiple signaling pathways downstream EGFR and MET receptors in resistant NSCLC 74
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors 67
Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study 67
Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by F-18-fluorothymidine 65
Molecular mechanisms of decreased aerobic glycolysis in non-small lung cancer treated with EGFR tyrosine kinase inhibitors. European Society for Molecular Imaging Meeting 65
Multimodal imaging of tumor invasion by targeting integrin ?v?3 in a preclinical model of lung metastasis 63
Changes of Glycolytic Pathway in Response to Efficient Inhibition of EGFR Signaling in Non-small Cell Lung Cancer (NSCLC) 62
18F-FLT PET/CT for Detection of Functional Cross-talk between MET and EGFR in Non-small Cell Lung Cancer Resistant to EGFR Inhibitors 62
Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy 61
Changes of glycolytic pathway and upregulation of oxidative phosphorylation in BCR-ABL-driven human leukemia cells treated with imatinib 60
Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention-Exploring the State of the Art 58
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 58
Early reduction of 18F-FDG uptake in non-small lung cancer treated with EGFR tyrosine kinase inhibitors reflects reversal of Warburg effect and reactivation of oxidative phosphorylation. 56
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer 55
Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells 54
Preclinical imaging for targeting cancer immune evasion 52
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 52
A reversible shift of driver dependence from egfr to notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors 51
Dynamic roles of neutrophil extracellular traps in cancer cell adhesion and activation of Notch 1-mediated epithelial-to-mesenchymal transition in EGFR-driven lung cancer cells 51
Non-Canonical Role of PDK1 as a Negative Regulator of Apoptosis through Macromolecular Complexes Assembly at the ER–Mitochondria Interface in Oncogene-Driven NSCLC 49
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 43
Preclinical Imaging in Targeted Cancer Therapies 43
Neutrophil Extracellular Traps as an Adhesion Substrate for Different Tumor Cells Expressing RGD-Binding Integrins 43
Monitoring the effects of combined treatment with EGFR and MET inhibitors in non-small cell lung cancer and synergy quantification by 18F-FLT PET/CT 42
Notch1-dependent targets in cancer stem cell resistance to EGFR inhibitors in oncogene-driven non-small cell lung cancer 42
Coordinate modulation of glycolytic enzymes and OXPHOS by imatinib in BCR-ABL driven chronic myelogenous leukemia cells 41
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 37
18F-FLT PET/CT imaging of inositol trisphosphate receptor type 3-mediated enhancement of EGFR and MET co-targeting efficacy in non-small cell lung cancer 37
Preclinical imaging in oncology: advances and perspectives 37
Early F-18-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors 35
18F-FLT PET/CT as a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 35
18F-FLT PET/CT to Detect Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer. 33
Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System 30
Combination of Abeta secretion and oxidative stress in an Alzheimer-like cell line leads to the over-expression of the nucleotide excision repair proteins DDB2 and XPC 29
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography 29
Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors 28
18F-FLT PET/CTas a surrogate biomarker for synergy quantification in EGFR targeted combination therapy of NSCLC 28
Does a role for selenium in DNA damage repair explain apparent controversies in its use in chemoprevention? 27
18F-FLT PET/CT to detect reversal of EGFR TKI resistance due to MET amplification by MET inhibitors in NSCLC 27
18F-FLT PET/CT to Detect Reversal of Concurrent Mechanisms of Resistance to EGFR TKIs in Non-Small Cell Lung Cancer 26
[18]F-FLT PET-CT to detect reversal of EGFR TKI resistance due to MET amplification by MET inhibitors in NSCLC. 26
Combined Imaging with 18F-FLT PET/CT and 99m-Tc-Hynic-Annexin V SPECT for Personalized Therapy with EGFR Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer 25
Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer 24
Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells 24
Effect of Soluble Factors Released from Porcine Freeze-Dried Lung Tissue (FDLT) on Modulation of Cell Growth and EMT Signature in Non-Small Cell Lung Cancer (NSCLC)—A Preliminary In Vitro Study 22
Neutrophil extracellular traps as drivers of epithelial-mesenchymal transition in cancer cells 22
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 22
Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in NSCLC 21
Alzheimer's Disease-Associated Neurotoxic Peptide Amyloid-B Impairs Base Excision Repair in Human Neuroblastoma Cells 20
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 16
Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells 16
Addition of metformin to anti-PD-1/PD-L1 drugs activates antitumor immune response in peripheral immune cells of NSCLC patients 15
Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood 12
Totale 2.214
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.619
article - articoli 6.041
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.660
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 0 0 0 5 8 7 15
2024/2025861 15 14 79 42 195 40 1 58 54 62 156 145
2025/20261.318 62 95 73 136 328 90 215 59 116 96 48 0
Totale 2.214